Solution for infusion 10 mg

Indication: 

In combination with carboplatin and etoposide is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC).

In combination with carboplatin and nanoparticle albumin-bound paclitaxel for first-line therapy in

adult patients with locally advanced or metastatic squamous non-small cell lung cancer (squamous-NSCLC).